Last update 21 Nov 2024
Recombinant anti-RANKL monoclonal antibody (Pacific Meinuoke)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism RANKL inhibitors(Tumor necrosis factor ligand superfamily member 11 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Recombinant anti-RANKL monoclonal antibody (Pacific Meinuoke)一项随机、双盲、平行对照，比较重组抗RANKL单抗注射液与Prolia®治疗中国骨折高风险的绝经后妇女骨质疏松症的临床有效性、安全性和免疫原性的Ⅲ期比对研究
[Translation] A randomized, double-blind, parallel-controlled phase III study comparing the clinical efficacy, safety, and immunogenicity of recombinant anti-RANKL monoclonal antibody injection with Prolia® in the treatment of osteoporosis in postmenopausal women at high risk of fracture in China
一项单中心、随机、双盲、单剂量、平行对照的重组抗RANKL单抗注射液和地舒单抗注射液（Prolia®）在健康男性受试者中的药代动力学、药效学、安全性和免疫原性比对的临床研究
[Translation] A single-center, randomized, double-blind, single-dose, parallel-controlled clinical study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of recombinant anti-RANKL monoclonal antibody injection and denosumab injection (Prolia®) in healthy male subjects
100 Clinical Results associated with Recombinant anti-RANKL monoclonal antibody (Pacific Meinuoke)
Login to view more data
100 Translational Medicine associated with Recombinant anti-RANKL monoclonal antibody (Pacific Meinuoke)
Login to view more data
100 Patents (Medical) associated with Recombinant anti-RANKL monoclonal antibody (Pacific Meinuoke)
Login to view more data
100 Deals associated with Recombinant anti-RANKL monoclonal antibody (Pacific Meinuoke)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoporosis, Postmenopausal | Phase 3 | CN | 29 Oct 2024 | |
| Multiple Myeloma | IND Application | CN | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free